Amanda Carbonell

904 total citations
2 papers, 40 citations indexed

About

Amanda Carbonell is a scholar working on Neurology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amanda Carbonell has authored 2 papers receiving a total of 40 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Neurology, 1 paper in Surgery and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Amanda Carbonell's work include Neurofibromatosis and Schwannoma Cases (2 papers), Neuroblastoma Research and Treatments (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Amanda Carbonell is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (2 papers), Neuroblastoma Research and Treatments (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Amanda Carbonell collaborates with scholars based in United States. Amanda Carbonell's co-authors include Geraldine O’Sullivan Coyne, Alice P. Chen, Cecilia Tibery, Patricia Whitcomb, Eva Dombi, Joanne Derdak, Andrea M. Gross, Brigitte C. Widemann, Andrea Baldwin and Sadhana Jackson and has published in prestigious journals such as Journal of Clinical Oncology and Neuro-Oncology Advances.

In The Last Decade

Amanda Carbonell

2 papers receiving 39 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda Carbonell United States	2	36	20	15	6	4	2	40
Mohammad A Abdulrazzak United States	3	25 0.7×	12 0.6×	17 1.1×	6 1.0×		5	29
Elisabeth Medeiros France	3	23 0.6×	28 1.4×	28 1.9×	7 1.2×	4 1.0×	4	49
Jana Zeleňáková Slovakia	3	24 0.7×	8 0.4×	14 0.9×	8 1.3×		7	32
V. Peter Collins Sweden	2	21 0.6×	14 0.7×	4 0.3×	8 1.3×	6 1.5×	2	24
Timothy Malisch United States	4	41 1.1×	10 0.5×	14 0.9×	5 0.8×		4	47
Paul Emile Labeyrie France	2	52 1.4×	7 0.3×	14 0.9×	5 0.8×		2	55
Annemarie Brandhofe Germany	4	14 0.4×	12 0.6×	12 0.8×	2 0.3×	1 0.3×	4	31
Quentin Alias France	4	43 1.2×	14 0.7×	7 0.5×	9 1.5×		9	54
Colleen Lechtenberg United States	2	21 0.6×	21 1.1×	10 0.7×	1 0.2×	3 0.8×	2	41
Berk Çimenoğlu Türkiye	3	20 0.6×	9 0.5×	9 0.6×	5 0.8×		9	31

Countries citing papers authored by Amanda Carbonell

Since Specialization

Citations

This map shows the geographic impact of Amanda Carbonell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Carbonell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Carbonell more than expected).

Fields of papers citing papers by Amanda Carbonell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Carbonell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Carbonell. The network helps show where Amanda Carbonell may publish in the future.

Co-authorship network of co-authors of Amanda Carbonell

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Carbonell. A scholar is included among the top collaborators of Amanda Carbonell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Carbonell. Amanda Carbonell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Jackson, Sadhana, Eva H. Baker, Andrea M. Gross, et al.. (2020). The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neuro-Oncology Advances. 2(1). vdaa095–vdaa095. 23 indexed citations

2.

Coyne, Geraldine O’Sullivan, Andrea M. Gross, Eva Dombi, et al.. (2020). Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).. Journal of Clinical Oncology. 38(15_suppl). 3612–3612. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact